What question did this study set out to answer?

Investigate the potential of rylenecarboximides as effective agents in cancer theranostics and therapy.

From Dyestuff Chemistry to Cancer Theranostics: The Rise of Rylenecarboximides

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial explores photostable rylenecarboximides for cancer imaging and therapy, suggesting improved outcomes.

Investigate the potential of rylenecarboximides as effective agents in cancer theranostics and therapy.
Examined the design concepts and structure-property relationships of rylenecarboximides.
Utilized fluorescence and photoacoustic imaging techniques for cancer detection.
Evaluated the effectiveness of rylenecarboximides in photodynamic and photothermal cancer treatments.
Rylenecarboximides demonstrated high photostability and favorable photophysical properties.
PDI-based agents showed significant promise in fluorescence bioimaging and photothermal therapy.
Combination therapies using PDIs have potential benefits in chemotherapeutic applications.

Ji et al. (2019) studied this question.

View Full Paper

Ask AI

Bookmark